We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Antibodies by Design and JPT Peptide Technologies Announce Cooperation Agreement

Both parties agree to co-market the rapid generation of monoclonal antibodies by Antibodies by Design and the complementary peptide-based services and products from JPT.
News

Biotage Receives its Largest Order to Date

Instruments, which originate from the recently acquired company Argonaut, will be used by chemists to enhance the processes used in the development of pharmaceuticals.
News

Thermo Electron Acquires Provider of Mass Spectrometry Ion Filtering Device

Thermo has purchased Ionalytics Corporation a developer of a dynamic ion filtering device used with mass spectrometers in bioanalysis, proteomics and drug discovery.
News

Tripos Introduces LeadDiscovery Program

Tripos' LeadDiscovery program is designed to develop leads for its pharmaceutical and biotechnology customers.
News

A New Tool for Small Crystals - FOX2D CU 25_25P Symmetrical Focussing Optics

Xenocs has recently introduced the FOX2D CU 25_25P multilayer optics dedicated to the analysis of small protein crystals.
News

Bruker Daltonics Obtains South Korean Registration of Autoflex II

Bruker takes the step of registering its autoflex II systems as medical devices in the Republic of Korea.
News

Sareum Collaborates with Almirall Prodesfarma

Sareum to provide protein structure determination capabilities to accelerate drug discovery research at Almirall
News

Craft Technologies Uses Selerity Technologies' Polaratherm

Using Selerity's Polaratherm, Craft Technologies has conducted experiments to separate retinol and retinyl esters, carotenoids, and tocopherols
News

TCS Bags Drug Discovery Deal from Italian Bio-Tech Firm

The Life Sciences R&D Division of TCS will work on a target protein identified by Congenia as a key protein involved in several age-related diseases.
News

CST Announces Pilot Study to Evaluate PhosphoScan™ Platform for Kinase Inhibitor Phosphoproteomic Profiling

Cell Signaling Technology, Inc. (CST) has announced an agreement with Novartis under which a pilot study was performed using CST's PhosphoScan™ technology to identify phosphorylation sites and prospective biomarkers of protein kinase targets.
Advertisement